EssilorLuxottica $EL (-0,2%) combines eyecare, strong brands such as Ray-Ban and Oakley, its own retail operations, and, increasingly, smart glasses.
Operationally, the picture remains strong: H1 2026 revenue up 9.7% on a currency-adjusted basis, adjusted operating profit up 15%. In Q2, the myopia business grew by 24%, and revenue from AI glasses nearly doubled.
The governance conflict remains a risk, but no operational weakness has been evident so far.
For me, this is an interesting quality compounder that I’m continuing to monitor.
